Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-033973

Chief Executive Officer sold 32,410 shares at $185.60 ($6,015,296)

  • Chief Executive Officer acquired 32,410 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
TABUTEAU HERRIOT Chief Executive Officer 2026-02-02 Option exercise 10b5-1 +32,410 $8.02 $259,928 39,639 D: show line 1 in the form
TABUTEAU HERRIOT Chief Executive Officer 2026-02-02 Sale 10b5-1 −32,410 $185.60 $6,015,296 7,229 D: show line 2 in the form
Open-market sales · 32,410 sh · avg $185.60 · $6,015,296

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
TABUTEAU HERRIOT Chief Executive Officer 2026-02-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −32,410 0 D: show line 3 in the form
Loading xslF345X05/ownership.xml…